Clinical Trial

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

Name: Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) — clinical trial record (NCT02421705)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Aim: More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2015-04-20; most recent amendment 2023-02-07.

Trial Details

NCT Number	NCT02421705
Lead Sponsor	KU Leuven
Conditions	IBS, Ulcerative Colitis, Active, Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms), Healthy Controls, Crohn's Disease, Active, Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)
Enrollment	99,999,999 participants
Start Date	2010-02
Primary Completion	2099-01 (estimated)
Study Completion	2099-01 (estimated)
Updated on ClinicalTrials.gov	2023-02-08